| Perjeta | 🇺🇸United States | 420MG/14ML | vial | Marketed | Genentech |
| PhesgoCombination | 🇺🇸United States | 1,200MG, 600MG | injectable | Marketed | Genentech INC |
| Poherdy | 🇺🇸United States | 420MG/14ML | injectable | Marketed | Shanghai Henlius Biotech |
| Perjeta | 🇪🇺European Union | | | Authorised | Roche Registration GmbH |
| Perjeta | 🇮🇹Italy | | Concentrato per soluzione per infusione | Authorised | Abacus Medicine A/S |
| Perjeta | 🇮🇹Italy | | Concentrato per soluzione per infusione | Authorised | Roche Registration GMBH |
| Perjeta | 🇨🇦Canada | 420 MG / 14 ML | Solution | Marketed | Hoffmann-LA Roche Limited |
| PhesgoCombination | 🇪🇺European Union | | | Authorised | Roche Registration GmbH |
| Perjeta 420 MG Concentrado Para Solucion Para Perfusion | 🇪🇸Spain | 30,0 mg | concentrado para solución para perfusión | Marketed | Roche Registration Gmbh |
| Perjeta 420 MG Concentrado Para Solucion Para Perfusion | 🇪🇸Spain | 30 mg | concentrado para solución para perfusión | Marketed | Roche Registration Gmbh |
| Perjeta 420 MG Concentrado Para Solucion Para Perfusion | 🇪🇸Spain | 30,0 mg | concentrado para solución para perfusión | Marketed | Roche Registration Gmbh |
| Perjeta 420 MG Concentrado Para Solucion Para Perfusion | 🇪🇸Spain | 30 mg | concentrado para solución para perfusión | Marketed | Roche Registration Gmbh |
| Perjeta 420 MG Concentrado Para Solucion Para Perfusion | 🇪🇸Spain | 30 mg | concentrado para solución para perfusión | Marketed | Roche Registration Gmbh |
| Poherdy | 🇪🇺European Union | | | Authorised | Organon N.V. |
| Perjeta | 🇧🇷Brazil | | | Authorised | Produtos Roche Químicos e Farmacêuticos S.A. |
| Phesgo 600 MG/600 MG Solucion InyectableCombination | 🇪🇸Spain | 600 mg + 600 mg | solución inyectable | Marketed | Roche Registration Gmbh |
| Phesgo 600 MG/600 MG Solucion InyectableCombination | 🇪🇸Spain | 600 mg + 600 mg | solución inyectable | Marketed | Roche Registration Gmbh |
| Phesgo 1200 MG/600 MG Solucion InyectableCombination | 🇪🇸Spain | 1200 mg + 600 mg | solución inyectable | Marketed | Roche Registration Gmbh |
| Phesgo 1200 MG/600 MG Solucion InyectableCombination | 🇪🇸Spain | 1200 mg + 600 mg | solución inyectable | Marketed | Roche Registration Gmbh |
| Perjeta® | 🇷🇸Serbia | 420mg | koncentrat za rastvor za infuziju | Authorised | Roche DOO Beograd |
| Perjeta-HerceptinCombination | 🇨🇦Canada | 420 MG / 14 ML + 440 MG / VIAL | Kit, Powder For Solution, Solution | Marketed | Hoffmann-LA Roche Limited |
| PhesgoCombination | 🇮🇹Italy | | Soluzione iniettabile | Authorised | Roche Registration GMBH |
| Perjeta 420 MG Concentrado Para Solucion Para Perfusion | 🇪🇸Spain | 30 mg | concentrado para solución para perfusión | Authorised | Roche Registration Gmbh |
| Perjeta 420 MG Concentrado Para Solucion Para Perfusion | 🇪🇸Spain | 30 mg/ml | concentrado para solución para perfusión | Authorised | Roche Registration Gmbh |
| Poherdy | 🇮🇹Italy | | Concentrato per soluzione per infusione | Authorised | N.V. Organon |
